CNBC
US · 26 mins ago
AI scored
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk
—Accuracy
—Bias
0Ratings
💬 0Comments
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk
New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in Novo's Ozempic and Wegovy.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!